Health authorities in South Africa announced Tuesday they were putting a pause on the single-shot Johnson & Johnson COVID-19 vaccine after six recipients, out of nearly 7 million total in the US, experienced rare blood clots. Host Carol Hills speaks with Mosa Moshabela, professor of public health at the University of KwaZulu-Natal, from Durban.
We want to hear your feedback so we can keep improving our website, theworld.org. Please fill out this quick survey and let us know your thoughts (your answers will be anonymous). Thanks for your time!